About this trial
Traditionally, general anesthesia is maintained with inhalational anesthesia (GAS), but there is a gap in knowledge regarding whether intravenous anesthesia (IV) can prevent deleterious postoperative outcomes in the geriatric surgical population. The goal of this clinical trial is to determine whether intravenous anesthesia (IV) leads to a decreased incidence of postoperative delirium (POD), postoperative cognitive dysfunction (POCD), and functional decline, and improved patient-reported outcomes (PROs) in older adults undergoing non-cardiac surgery when compared to the standard inhalational anesthesia (GAS). This single-center, 1:1 randomized, double-blind (patient \& outcome assessor) clinical trial will compare inhalational vs. intravenous anesthesia on POD, POCD, functional status, patient-reported outcomes (PROs), and blood-based biomarkers in older patients undergoing elective, inpatient, non-cardiac surgery. Upon enrollment, 260 women and men ≥ 70 years undergoing elective noncardiac surgery under general anesthesia will be randomized to 2 groups: TIVA or GAS.
Eligibility criteria
Qualifiers
Men and women ≥ 70 years
Sufficient vision and hearing to complete all tests
Proficient in spoken and written English
Scheduled for elective, inpatient, noncardiac surgery, expected to last at least 120 minutes requiring general anesthesia
Disqualifiers
Urgent or emergent surgery
Diagnosed dementia (or MoCA<19)
History of Parkinson's disease, major psychiatric disease (Schizophrenia), or severe traumatic brain injury
Ongoing alcohol or substance abuse (per DSM V criteria)
Trial design
Treatments tested in this trial
- Sevoflurane
- Propofol